M42 and Siemens Healthineers, a leading medical technology company, have collaborated to advance healthcare transformation across UAE and emerging markets, with a particular emphasis on Africa. Signed at the Abu Dhabi Future Health Summit 2026 (ADFHS), by Kareem Shahin, CEO, Digital Health Solutions Platform and Group Chief Digital Officer, M42 and Dr. Kevin Massoudi, Vice President & Head of Public Sector, Siemens Healthineers, Middle East and Africa, the partnership will explore joint value propositions and technology-enabled solutions to strengthen disease prevention, screening and earlier detection. The collaboration will also enable proactive approaches to population health with the aim of helping health systems identify health risks sooner for more timely intervention.
The partnership will bring together M42’s expertise in population-scale digital health, healthcare data and AI with Siemens Healthineers’ capabilities in medical imaging, diagnostics and AI-enabled digital technologies. Together, the organizations will explore joint value propositions and technology-enabled-solutions that can strengthen disease prevention and screening, support earlier detection, and enable proactive approaches to population health with the aim of helping health systems identify health risks earlier and support more timely intervention. The focus is to support healthcare providers across the patient pathway and respond to the needs of health systems in the UAE and emerging markets, including Africa.
Dimitris Moulavasilis, Group Chief Executive Officer of M42, said: “Healthcare transformation must ultimately be measured by its ability to improve outcomes for people, wherever they live. At M42, our ambition is to take the innovation, capabilities and experience we have built in Abu Dhabi and apply them at scale to some of the world’s most pressing healthcare challenges. Our partnership with Siemens Healthineers reflects that ambition, bringing together two organizations with complementary strengths and a shared commitment to advancing more proactive, accessible and sustainable models of care.”
M42 brings experience in delivering digital health capabilities at population scale in the UAE through Abu Dhabi Health Data Services (ADHDS), including Malaffi, the Abu Dhabi Health Information Exchange; Sahatna, Abu Dhabi’s unified digital health patient portal; Shafafiya, its insurance management platform; and the E-Prescriptions platform. These are complemented by AI-driven analytics and predictive and personalized care models. Siemens Healthineers is a leading global medical technology company with expertise in medical imaging, diagnostics, cancer care and minimally invasive therapies, supported by digital technology and artificial intelligence. The company’s technologies, solutions and services support healthcare providers across the patient pathway, from diagnosis to treatment and follow-up, with a focus on improving access, efficiency and clinical excellence.
Kareem Shahin, Chief Executive Officer, Digital Health Solutions Platform and Group Chief Digital Officer, M42 said: “This agreement marks an important step in our collaboration with Siemens Healthineers and reflects the complementary strengths of our two organizations. By connecting population-scale digital health, healthcare data and AI with advanced imaging, diagnostics and medical devices, we can explore new ways to strengthen prevention and screening and help health systems act earlier. Our ambition is to combine our capabilities to drive impact and growth internationally, while continuing to support innovation and preventive care at home.”
Vivek Kanade, Managing Director, Siemens Healthineers, Middle East and Africa, said: “By bringing together our capabilities with M42, we have the opportunity to explore solutions that support earlier diagnosis and treatment and more connected care. Our aim is to help elevate healthcare in the UAE and emerging markets, including Africa, while supporting healthcare providers in improving access, efficiency and clinical excellence across the patient pathway. With our purpose to pioneer breakthroughs in healthcare for everyone, everywhere, sustainably, we see our partnership with M42 as an important step towards expanding access to quality care where it is needed.” The MoU supports M42’s continued international expansion and its ambition to bring health innovation developed in Abu Dhabi to markets where it can deliver meaningful impact. It also reflects Abu Dhabi’s growing role as a hub for healthcare innovation with global relevance.
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.